API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. F /
  3. 2VF0.F

HEMOSTEMIX INC. (2VF0 F) stock market data APIs

€0.051 0(0%) as of October 29, 2024
Price chart is built with Anychart

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

HEMOSTEMIX INC. Financial Data Overview

0.051
0.051
-
0.051
0.051
0.019-0.067
11 202 K
167 M
0
0.199
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '2VF0',
Type: 'Common Stock',
Name: 'HEMOSTEMIX INC.',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'CA4236943060',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

HEMOSTEMIX INC. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -1 533 412
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get HEMOSTEMIX INC. Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get HEMOSTEMIX INC. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get HEMOSTEMIX INC. latest news via APIs

InvestmentPitch Media Video Discusses Hemostemix and its Hiring of 4 Biotechnologists to Re-Establish Production of ACP-01 in Montreal and Applying for Grants to Fund Up to 75% of 5-Year Expenses

VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0), an autologous stem cell therapy company, is hiring four biotechnologists to re-est...
  • CLINICAL STUDY
  • HEALTH
  • HEMOSTEMIX VIDEO
  • INVESTMENTPITCH MEDIA AND HEMOSTEMIX INC
  • INVESTMENTPITCH MEDIA VIDEO
  • ISCHEMIC CARDIOMYOPATHY
  • MCGILL UNIVERSITY HEALTH CENTR
  • THOMAS SMEENK
  • TSX VENTURE EXCHANGE:HEM

InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01

VANCOUVER, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF), an autologous stem cell therapy company, has received a $250,000 Letter of Commitment for fun...
  • CLINICAL TRIAL ACP-01
  • HEMOSTEMIX VIDEO
  • INVESTMENTPITCH MEDIA AND HEMOSTEMIX INC
  • INVESTMENTPITCH MEDIA VIDEO
  • MCGILL UNIVERSITY HEALTH CENTR
  • PARTNERSHIPS
  • THOMAS SMEENK
  • TSX VENTURE EXCHANGE:HEM
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com